Tapestry, Capri file notice to appeal court decision blocking their $8.5 billion merger

Date:

Share post:


Tapestry and Capri Holdings have filed their notice to jointly appeal the decision by a U.S. District judge to temporarily halt the merger between the makers of Coach and Michael Kors handbags, according to a court filing Monday

NEW YORK — Tapestry Inc. and Capri Holdings Ltd. have filed their notice to jointly appeal the decision by a U.S. District judge to temporarily halt the merger between the makers of Coach and Michael Kors handbags, according to a court filing Monday.

In her ruling Thursday, U.S. District Judge Jennifer Rochon noted that Tapestry and Capri are “close competitors” and that the merger would result in “the loss of head-to-head competition” and raise prices for shoppers.

The ruling came six months after the Federal Trade Commission sued to block Tapestry’s $8.5 billion acquisition of Capri, saying that the deal would eliminate direct competition between the fashion companies’ brands in the so-called affordable luxury handbag arena.

Tapestry has been on an acquisition binge for the past several years, and already owns Kate Spade New York, Stuart Weitzman and Coach. Capri owns the Versace, Michael Kors and Jimmy Choo brands.

The agency also said that the deal announced in August 2023 threatens to eliminate the incentive for the two companies to vie for employees and could depress employees’ wages and workplace benefits. The combined Tapestry and Capri would employ roughly 33,000 people worldwide, the agency said.

Tapestry said in an emailed statement to The Associated Press on Thursday that the decision granting the FTC’s request for a preliminary injunction was “disappointing” and “incorrect on the law and the facts.”



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

Lawsuit alleges first deaths from disastrous 2023 train derailment in Ohio

A lawsuit alleging for the first time that people died because of the disastrous 2023 East Palestine...

Trump and Trudeau speak and plan to do so again before tariffs start on Tuesday

Ahead of tariffs starting Tuesday, President Donald Trump posted on social media that he spoke Monday morning...

Ontario premier 'ripping up contract' with Musk's Starlink in response to tariffs

The leader of Canada’s most populous province of Ontario says he’s ripping up a contract with Elon...

Crews return to the Potomac River to recover wreckage from DC midair collision

ARLINGTON, Va. -- Crews were on the scene on the Potomac River on Monday to retrieve the...

Glass half empty? Germany's annual beer sales down again despite soccer's European Championship

German beer sales declined in 2024 despite the country hosting the European Football Championship, continuing a long-term...

Stock market today: Asian shares slip as worries grow about Trump's tariffs

TOKYO -- Asia shares mostly fell in Monday trading as worries grow about President Donald Trump imposing...

SoftBank and OpenAI set up joint company to push artificial intelligence services

TOKYO -- Japanese technology giant SoftBank Group and OpenAI stepped up their AI partnership Monday, setting up...

China renews threat to retaliate against US tariffs

TAIPEI, Taiwan -- U.S. President Donald Trump's trade war with Canada, Mexico and China is ramping up...